Alpha tau medical ltdDRTS.US Overview

US StockHealthcare

(No presentation for DRTS)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

DRTS Overall Performance

DRTS AI Analysis & Strategy

DRTS Recent Performance

1.00%

Alpha tau medical ltd

0.81%

Avg of Sector

-1.14%

S&P500

DRTS PowerScanner

DRTS Key Information

DRTS Valuation Metrics

DRTS Earnings Table

DRTS Profile

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.